VACCINE COMPOSITION FOR PREVENTING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION

• Main Authors: KIM, Mi Young, CHO, Young Ran, PARK, Bo Yeong, LEE, Hyo Jin, GIL, Areum, LIM, Hee Ji, PARK, Young Keun, OH, Ye Eun, JOEL, Maslow, JEON, Bo Hyun, CHRISTINE, Claire Roberts, JEONG, Moon Sup, CHO, Byung Mun, LEE, Jung Ah, PARK, Gee Ho, YEU, Song Yion, HWANG, Yun Ho
• Format: Patent
• Language: English; French; German
• Published: 28.08.2024
• Subjects: CHEMISTRY; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PEPTIDES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

The present invention relates to a vaccine composition for preventing severe acute respiratory syndrome coronavirus 2 infection. The vaccine composition for preventing severe acute respiratory syndrome coronavirus 2 infection according to the present invention comprises spike and ORF3a or nucleocapsid as an antigen against SARS-CoV-2. The vaccine composition has a significant effect of inducing antibody immune responses and T-cell immune responses by a plurality of co-expressed antigens compared to those comprising one antigen, and thus can be variously used in the field of prevention of severe acute respiratory syndrome coronavirus 2 infection.